Literature DB >> 3694260

Structurally different neuronal nicotinic acetylcholine receptor subtypes purified and characterized using monoclonal antibodies.

P J Whiting1, R Liu, B J Morley, J M Lindstrom.   

Abstract

Acetylcholine receptors that bind nicotine with high affinity but do not bind alpha-bungarotoxin have recently been immunoaffinity purified from brains of chickens and rats (Whiting and Lindstrom, 1986a, b; Whiting and Lindstrom, 1987a). Antisera to these receptors bind to the nicotinic receptors that regulate cation channel opening on chick ciliary ganglion neurons (Stollberg et al., 1986) and rat PC12 cells (Whiting et al., 1987c). Here we report the preparation and characterization of monoclonal antibodies to chicken brain acetylcholine receptors. These monoclonal antibodies are used to identify 2 nicotinic receptor subtypes in the chicken brain. The 2 subtypes have very similar affinities for nicotine and other cholinergic agonists and antagonists. However, they are structurally distinct, having very similar or identical alpha subunits (Mr 49,000), but different beta subunits (Mr 59,000, or for beta' subunit, Mr 75,000). Evidence is presented that suggests that the subunit stoichiometry of these neuronal nicotinic acetylcholine receptors is alpha n = 2 - 3 beta n = 2 - 3. Different levels of receptor subtype expression were detected in embryonic, compared to adult, chicken brain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3694260      PMCID: PMC6569086     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  17 in total

1.  Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons.

Authors:  C Léna; A de Kerchove D'Exaerde; M Cordero-Erausquin; N Le Novère; M del Mar Arroyo-Jimenez; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 2.  Immunohistochemistry of cholinergic receptors.

Authors:  H Schröder
Journal:  Anat Embryol (Berl)       Date:  1992-10

Review 3.  Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance.

Authors:  Merouane Bencherif
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

4.  Heterogeneous organization and connectivity of the chicken auditory thalamus (Gallus gallus).

Authors:  Yuan Wang; Diego A R Zorio; Harvey J Karten
Journal:  J Comp Neurol       Date:  2017-07-13       Impact factor: 3.215

Review 5.  Molecular studies of the neuronal nicotinic acetylcholine receptor family.

Authors:  J Lindstrom; R Schoepfer; P Whiting
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

6.  cAMP-dependent protein kinase inhibits α7 nicotinic receptor activity in layer 1 cortical interneurons through activation of D1/D5 dopamine receptors.

Authors:  Pragya Komal; Jasem Estakhr; Melad Kamran; Anthony Renda; Raad Nashmi
Journal:  J Physiol       Date:  2015-06-25       Impact factor: 5.182

7.  Rapsyn clusters neuronal acetylcholine receptors but is inessential for formation of an interneuronal cholinergic synapse.

Authors:  G Feng; J H Steinbach; J R Sanes
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

8.  Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain.

Authors:  Michael J Marks; Tristan D McClure-Begley; Paul Whiteaker; Outi Salminen; Robert W B Brown; John Cooper; Allan C Collins; Jon M Lindstrom
Journal:  J Pharmacol Exp Ther       Date:  2011-01-12       Impact factor: 4.030

9.  Alpha 4-2 beta 2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs.

Authors:  J Connolly; J Boulter; S F Heinemann
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

10.  Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation.

Authors:  Raad Nashmi; Henry Lester
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.